AXXIN
LIVE

Serial Number

79323461

Owner

Axxin Pty Ltd

Attorney

Jason Paul Blair

Filing Date

Jun 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AXXIN Trademark

Serial Number: 79323461 • Registration: 7134872

AXXIN is a trademark filed by Axxin Pty Ltd on June 3, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Axxin Pty Ltd (3 trademarks)

Ground Floor,

Entity Type: 82

Trademark Details

Filing Date

June 3, 2021

Registration Date

August 15, 2023

Published for Opposition

May 30, 2023

Goods & Services

Custom manufacture of medical devices, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors, instruments, and cartridges for measuring and analyzing molecular, nucleic acid, and immunoassay reagents using in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications for identifying diseases or medical conditions, and for testing for specific DNA, pathogens, antigens, viruses and bacteria; information, advisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistry

Scientific apparatus and instruments, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors and instruments for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for scientific testing purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria, none of the foregoing goods for medical diagnostic or treatment purposes; recorded software, downloadable software, and recorded and downloadable operating system software for controlling or operating and configuring biomedical sensors and instruments, analyzing test and sample results, managing assay test workflow and protocol design, and compiling and exporting medical test data for scientific, diagnostic, and medical treatment purposes; none of the foregoing used in the field of dentistry; none of the aforementioned goods in relation to access control products, video intercom products, audio intercom products, surveillance products, cameras including but not limited to digital cameras, network cameras, web cameras and ip-cameras, video encoders, video decoders, network document servers, print servers, network video products, radars, speakers, microphones, software and accessories for the above mentioned goods

Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing services; information, advisory and consultancy services in relation to the aforementioned; none of the foregoing used in the field of dentistry

Biomedical apparatus and instruments, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors and instruments for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for medical purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria for medical diagnostic or treatment purposes; none of the foregoing used in the field of dentistry

Design and development of medical devices, namely, optical, isothermal, chromatographic, cardiographic, microfluidic, photometric, chemical, genetic, and biological sensors, instruments, and cartridges for measuring and analyzing molecular reagents, nucleic acid reagents, and immunoassay reagents for medical purposes, namely, for identifying diseases or medical conditions via in vitro diagnostic (IVD) and non-in vitro diagnostic (non-IVD) applications, and for testing for specific DNA, pathogens, antigens, viruses and bacteria; design and development of computer hardware and software for controlling or operating and configuring biomedical sensors and instruments, analyzing test and sample results, managing assay test workflow and protocol design, and compiling and exporting medical test data for scientific, diagnostic, and treatment purposes; scientific research services; scientific laboratory services; medical research, analysis, and testing laboratories; none of the foregoing used in the field of dentistry; none of the aforementioned services in the fields of security surveillance and video surveillance

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 1, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 1, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 1, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 1, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 1, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 3, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 15, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 15, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 15, 2023 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 7, 2023 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Sep 2, 2023 LIMG
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 15, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 30, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 30, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 30, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 10, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 10, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 10, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 25, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 25, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 25, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 25, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 25, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 18, 2023 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 12, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 22, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 22, 2023 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2023 NREP
ATTORNEY REVIEW COMPLETED
Jan 19, 2023 ATRV
ATTORNEY REVIEW COMPLETED
Jan 19, 2023 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 12, 2023 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Dec 3, 2022 LIMG
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 18, 2022 GNFN
FINAL REFUSAL E-MAILED
Oct 18, 2022 GNFR
FINAL REFUSAL WRITTEN
Oct 18, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2022 TROA
REFUSAL PROCESSED BY IB
Apr 18, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 31, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 18, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 29, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2021 REPR